市场调查报告书
商品编码
1307988
动物抗生素和抗菌剂市场 - 按产品类型(四环素类、青霉素类、磺胺类、大环内酯类、氨基糖苷类、林可霉素类、氟喹诺酮类、头孢菌素类)、给药方式、动物类型和全球预测2023-2032年Animal Antibiotics and Antimicrobials Market - By Product Type (Tetracyclines, Penicillin, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins), By mode of delivery, Animal Type & Global Forecast 2023-2032 |
全球动物抗生素和抗菌剂市场将在2023-2032年期间大幅增长,其驱动因素是动物源性蛋白质的消费量和摄入量不断增加。
全球对动物源性蛋白产品的需求不断增加,加上人口不断增长,导致集约化动物养殖方式增多,从而增加了疾病爆发的风险。这就需要使用抗生素和抗菌剂来预防和治疗家畜感染,从长远来看,这将推动市场收入的增长。人畜共患病发病率的上升以及对疾病控制措施的需求进一步促进了市场增长。
根据美国疾病预防控制中心(CDC)的数据,科学家估计每10种已知的人类传染病中就有6种以上可通过动物传播,每4种新的或新出现的人类传染病中就有3种通过动物传播。此外,良好的政府法规促进了抗生素的合理使用,并实施了严格的动物健康管理准则,这对市场的形成起着至关重要的作用。
整个动物抗生素和抗菌剂市场根据产品、给药方式、动物和地区进行划分。
就产品而言,青霉素的市场份额将在2023年至2032年期间以可观的复合年增长率增长。由于青霉素可有效治疗多种细菌感染,其需求量不断增长。青霉素被认为是一线抗生素,对包括链球菌和葡萄球菌在内的各种细菌非常有效。此外,抗生素耐药菌的增加也产生了对青霉素等强效抗生素的需求,进一步推动了其在医疗领域的需求。
根据给药方式,2023-2032年口服溶液领域的动物抗生素和抗菌剂市场规模将实现可观增长。口服溶液给药方便,可有效治疗和预防家畜感染。此外,口服溶液能够实现精确的剂量控制,便于治疗大群动物,因此成为兽医专业人员和畜牧业者的首选。口服给药的简便性和改善动物健康状况的潜力促使畜牧业对这些产品的需求不断增加。
就动物而言,由于全球对动物蛋白产品的需求不断增长,到2032年,畜牧动物细分市场将在动物抗生素和抗菌剂行业中占据显著份额。随着集约化养殖越来越普遍,疾病爆发的风险也随之增加,因此有必要使用抗生素和抗菌药来预防和治疗感染。有效的疾病控制措施和动物健康状况的改善推动了畜牧业对这些产品的需求。
从区域来看,亚太地区动物抗生素和抗菌剂市场将在2032年实现可观的增长。快速的城市化和不断扩大的中产阶级导致了动物蛋白消费量的增加,推动了对有效预防和治疗家畜疾病的需求。此外,集约化养殖方式的兴起以及人们对动物健康和福利意识的提高也促进了该地区对这些产品需求的增长。
.8.3.1.德国
.8.4.1.日本
.8.5.1.巴西
.8.6.1.南非
Global Animal Antibiotics and Antimicrobials Market could grow significantly over 2023-2032, driven by the rising consumption and uptake of animal-based proteins.
The increasing global demand for animal-derived protein products, coupled with the growing population, has led to a rise in intensive animal farming practices, thereby increasing the risk of disease outbreaks. This necessitates using antibiotics and antimicrobials to prevent and treat infections in livestock, which will propel market revenue in the long run. The rising prevalence of zoonotic diseases and the need for disease control measures further contribute to market growth.
According to CDC, scientists estimate that over 6 out of every 10 known infectious illnesses in humans can be transmitted from animals, and 3 out of every 4 new or emerging infectious diseases in people spread from animals. Additionally, favorable government regulations promoting the judicious use of antibiotics and the implementation of strict guidelines for animal health management play a crucial role in shaping the market.
The overall animal antibiotics and antimicrobials market is segregated based on product, mode of delivery, animal, and region.
In terms of product, the market share from the penicillin segment will expand at a decent CAGR from 2023 to 2032. The demand for penicillin is growing due to its effectiveness in treating a wide range of bacterial infections. Penicillin is considered a first-line antibiotic and is highly effective against various bacteria, including streptococci and staphylococci. Besides, the rise of antibiotic-resistant bacteria has created a need for potent antibiotics like penicillin, further driving its demand in the medical field.
Based on the mode of delivery, the animal antibiotics and antimicrobials market size from the oral solutions segment will register appreciable growth over 2023-2032. Oral solutions offer convenient administration and are effective in treating and preventing infections in livestock. Moreover, they enable precise dosage control and facilitate the treatment of large groups of animals, making them a preferred choice for veterinary professionals and livestock farmers. The ease of oral administration and the potential for improved animal health outcomes contribute to the increasing demand for these products in the animal agriculture industry.
With respect to animal, the livestock animal segment will amass a notable share of the animal antibiotics and antimicrobials industry by 2032, attributed to the rising global demand for animal protein products. As intensive farming practices become more prevalent, the risk of disease outbreaks increases, necessitating the use of antibiotics and antimicrobials to prevent and treat infections. Effective disease control measures and improved animal health outcomes drive the demand for these products in the livestock industry.
Regionally, the Asia Pacific animal antibiotics and antimicrobials will accumulate appreciable gains through 2032. Rapid urbanization and the expanding middle class are leading to increased consumption of animal protein, driving the need for effective disease prevention and treatment in livestock. Additionally, the rise of intensive farming practices and the growing awareness of animal health and welfare contribute to the rising demand for these products in the region.
.8.3.1. Germany
.8.4.1. Japan
.8.5.1. Brazil
.8.6.1. South Africa